Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects.
about
Mechanisms of action of therapeutic antibodies for cancerOn safari to Random Jungle: a fast implementation of Random Forests for high-dimensional dataMembrane-bound TRAIL supplements natural killer cell cytotoxicity against neuroblastoma cellsClinical significance of serum soluble death receptor 5 concentration in locally advanced non-small cell lung cancer patients.TRAIL in cancer therapy: present and future challenges.Efficient RNA interference in patients' acute lymphoblastic leukemia cells amplified as xenografts in mice.NOXA as critical mediator for drug combinations in polychemotherapy.Enhanced anti-tumour effects of Vinca alkaloids given separately from cytostatic therapies.TRAIL receptor-targeted therapeutics: resistance mechanisms and strategies to avoid them.Absence of TNF-α enhances inflammatory response in the newborn lung undergoing mechanical ventilation.Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation.Accumulation of autophagosomes in breast cancer cells induces TRAIL resistance through downregulation of surface expression of death receptors 4 and 5.TRAIL-deficient mice exhibit delayed regression of retinal neovascularization.The prognostic value of the apoptosis pathway in colorectal cancer: a review of the literature on biomarkers identified by immunohistochemistry.Multiple effects of TRAIL in human carcinoma cells: induction of apoptosis, senescence, proliferation, and cytokine production.The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-κB by TRAIL.Impact of the p53 status of tumor cells on extrinsic and intrinsic apoptosis signaling.Divergent Roles for TRAIL in Lung DiseasesMesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour
P2860
Q28385366-725521C8-7FB9-4FAF-B6AD-9179ED864AAEQ33588377-2E311329-958C-4C6D-96BA-8CEC10F7F4EBQ33783162-A3F8E6D6-4EF3-40F0-A435-52A06DB63F3FQ33967735-07674CF5-C1E4-43DF-96BF-DE2E8ECC56DEQ34291312-7DA66D77-1723-4B4B-BE6C-ED4906DBBFAFQ35950948-740976D4-D018-4A1D-B830-2C27DE2EAE2CQ36071973-718143EB-C65E-4BAB-BF55-343C38FEB469Q36709220-B006EEA0-9DD3-4EC1-AB18-C091A8F42242Q36731174-FF29C7BF-D048-41BB-8048-FBD128A9F9ADQ36976617-A16F0C98-F03A-4316-A042-AC6337759111Q36979947-16C7D902-96C5-4CC7-9A16-FAEAA5E96827Q37299291-CC365733-4502-42C0-A919-CE2F0335485BQ37462599-71FCE6B7-26FF-446E-9C05-3AF9F98CF491Q38157864-2AA49046-B15C-4F1D-A218-7565E62259D9Q38517521-3CFBF1D7-6844-4B8A-BAB7-60CF5502F612Q39253903-7109F548-8246-44D9-9F01-E7357B6B4799Q40311218-B0A989F1-B655-4744-8BD9-C40F29348FF0Q55920968-10A037F9-D73D-481E-AAB6-3ABB9ED01BE5Q57174410-C94EDB2A-BAC8-4DB8-AD4E-DDD51BB29A44
P2860
Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Tumor necrosis factor-related ...... or-proximal apoptosis defects.
@en
type
label
Tumor necrosis factor-related ...... or-proximal apoptosis defects.
@en
prefLabel
Tumor necrosis factor-related ...... or-proximal apoptosis defects.
@en
P2093
P50
P1433
P1476
Tumor necrosis factor-related ...... or-proximal apoptosis defects.
@en
P2093
Agnieszka Toloczko
Christian Beltinger
Eva Baader
Irene Schmid
P304
P356
10.1158/0008-5472.CAN-04-4278
P407
P577
2005-09-01T00:00:00Z